Efficacy and Safety of Rosuvastatin 5 mg in Combination with Fenofibric Acid 135 mg in Patients with Mixed Dyslipidemia – A Phase 3 Study

Author： Roth Eli   Rosenson Robert   Carlson Dawn   Fukumoto Sandra   Setze Carolyn   Blasetto James   Khurmi Nardev   Stolzenbach James   Williams Laura  

Publisher： Springer Publishing Company

ISSN： 0920-3206

Source： Cardiovascular Drugs and Therapy, Vol.24, Iss.5-6, 2010-12, pp. : 421-428

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

One-Year Efficacy and Safety of Rosuvastatin + Fenofibric Acid Combination Therapy in Patients with Mixed Dyslipidemia: Evaluation of Dose Response

By Ferdinand Keith C.  

American Journal of Cardiovascular Drugs, Vol. 12, Iss. 2, 2012-04 ,pp. : 117-125

Adis International

Access to resources Recommend Favorite

Efficacy and Safety of Rosuvastatin and Fenofibric Acid Combination Therapy versus Simvastatin Monotherapy in Patients with Hypercholesterolemia and Hypertriglyceridemia: A Randomized, Double-Blind Study

By Roth Eli M.  

American Journal of Cardiovascular Drugs, Vol. 10, Iss. 3, 2010-06 ,pp. : 175-186

Adis International

Access to resources Recommend Favorite

Fenofibric Acid: In Combination Therapy in the Treatment of Mixed Dyslipidemia

By Yang Lily P.H.   Keating Gillian M.  

American Journal of Cardiovascular Drugs, Vol. 9, Iss. 6, 2009-12 ,pp. : 401-409

Adis International

Access to resources Recommend Favorite

Efficacy and Safety of Fenofibric Acid Co-Administered with Low- or Moderate-Dose Statin in Patients with Mixed Dyslipidemia and Type 2 Diabetes Mellitus: Results of a Pooled Subgroup Analysis from Three Randomized, Controlled, Double-Blind Trials

By Jones Peter H.  

American Journal of Cardiovascular Drugs, Vol. 10, Iss. 2, 2010-04 ,pp. : 73-84

Adis International

Access to resources Recommend Favorite

The effects of rosuvastatin alone or in combination with fenofibrate or omega 3 fatty acids on inflammation and oxidative stress in patients with mixed dyslipidemia

By Agouridis Aris P   Tsimihodimos Vasilis   Filippatos Theodosios D   Dimitriou Andromachi A   Tellis Costantinos C   Elisaf Moses S   Mikhailidis Dimitri P   Tselepis Alexandros D  

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 17, 2011-12 ,pp. : 2605-2611

Informa Healthcare

Access to resources Recommend Favorite